Update: Cormedix Q4 Adj. EPS $0.61 Misses $0.82 Estimate, Sales $128.600M Beat $127.022M Estimate

Cormedix (NASDAQ:CRMD) reported quarterly earnings of $0.61 per share which missed the analyst consensus estimate of $0.82 by 25.25 percent. This is a 177.27 percent increase over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $128.600 million which beat the analyst consensus estimate of $127.022 million by 1.24 percent. This is a 312.05 percent increase over sales of $31.210 million the same period last year.